Orum International and Hardy Diagnostics announce the new MULTIFLEX 1+2 active impact microbial air sampler. The MULTIFLEX 1+2 is one of the latest designs from Orum International, of Milan, Italy. The founders of Orum International have over 40 years of experience in producing microbial air samplers for environmental monitoring. Hardy Diagnostics is their exclusive distribution partner in North America.
Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides.
GE Healthcare Life Sciences and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.
Tessy Plastics Corp. announced their expansion of cleanrooms in two of their manufacturing facilities in Upstate New York. One of the plants is the corporate headquarters located in Skaneateles, NY and the other plant is located in Elbridge, NY.
New Cogmedix facility features multiple engineering and laser labs, vast certified cleanroom space, multiple training areas, and a dedicated customer convenience center fostering transparency and collaboration.
Precigen commenced the build-out of the nearly 5,000 square foot manufacturing facility in 2018 to support gene therapy manufacturing. The good manufacturing practices (GMP) facility was designed with agility and control in mind, focusing on rapid manufacturing and the ability to scale production appropriately to meet early stage clinical trial needs.
For the past few months, the clean room floor in High Bay 1 at NASA’s Jet Propulsion Laboratory in Pasadena, California, has been covered in parts, components and test equipment for the Mars 2020 spacecraft, scheduled for launch toward the Red Planet in July of 2020. But over the past few weeks, some of these components
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications and rare diseases through gene therapy, cell therapy, exosomes, novel molecules and combinations with existing pharmaceuticals, announced today that it has received funding from the Israeli Ministry of the Economy to build a gene therapy facility.
ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics, and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced the construction and qualification of a new Class
Bioquell offers a unique opportunity to broaden Ecolab’s portfolio of products, services, and solutions. Bioquell’s expertise in bio-decontamination and deep-cleaning utilizing vaporized hydrogen peroxide technologies complements Ecolab’s daily cleaning and disinfection offerings for cleanrooms and other high-grade environments.
This “farm of the future”, built by systems integrator GrowStack working in conjunction with TCE Electrical Ltd., is the latest research initiative to be led by CHAP and Stockbridge Technology Centre (STC), a pioneer in experimental and applied horticulture research since the 1950s.
Private equity firm Graham Partners has entered injection molded medical goods with an investment in Medbio LLC of Grand Rapids, Mich. Graham Partners acquired a majority interest in Medbio, effective July 18 for undisclosed terms, according to Graham managing principal Joe Heinmiller.
